[China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2015 version)]

Affiliations

• ¹ Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, 100021 Beijing, China.
• ² Fourth Hospital of Hebei Medical University, 050000 Shijiazhuang, China.
• ³ Tianjin Medical University Cancer Institute & Hospital, 300070 Tianjin, China.
• ⁴ Shenzhen People's Hospital, 518020 Shenzhen, China.
• ⁵ The Second Military Medical University Changhai Hospital, 200433 Shanghai, China.
• ⁶ Fudan University Zhongshan Hospital, 200032 Shanghai, China.
• ⁷ Jiangsu Cancer Hospital, 210009 Nanjing, China.
• ⁸ The 307th Hospital of Chinese People's Liberation Army, 100071 Beijing, China.
• ⁹ Chinese People's Liberation Army General Hospital, 100853 Beijing, China.
• ¹⁰ Beijing Cancer Hospital, 100142 Beijing, China.
• ¹¹ Jiangsu Province Hospital, 210029 Nanjing, China.
• ¹² Qinghai University Affiliated Hospital, 810000 Xining, China.
• ¹³ The First Affiliated Hospital of Guangzhou Medical Unversity, 510000 Guangzhou, China.
• ¹⁴ Zhejiang Cancer Hospital, 310022 Hangzhou, China.
• ¹⁵ Beijing Chest Hospital, Capital Medical University, 101149 Beijing, China.
• ¹⁶ Harbin Medical University Cancer Hospital, 150081 Harbin, China.
• ¹⁷ The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, China.
• ¹⁸ Nanfang Medical University Nanfang Hospital, 510515 Guangzhou, China.
• ¹⁹ Tongji University Affiliated Shanghai Pulmonary Hospital, 200433 Shanghai, China.
• ²⁰ The First Affiliated Hospital, Zhejiang University, 310003 Hangzhou, China.
• ²¹ Shanghai Chest Hospital, Shanghai Jiaotong University, 200030 Shanghai, China.
• ²² Changzhou Fourth People's Hospital, 213001 Changzhou, China.
• ²³ Fujian Cancer Hospital, 350014 Fuzhou, China.